Chargement en cours...
Immunotherapy for Prostate Cancer – Recent Developments and Future Challenges
Since the approval of sipuleucel-T for men with metastatic castrate resistant prostate cancer in 2010, great strides in the development of anti-cancer immunotherapies have been made. Current drug development in this area has focused primarily on antigen specific [i.e. cancer vaccines and antibody ba...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116461/ https://ncbi.nlm.nih.gov/pubmed/24477411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-013-9479-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|